Gut microbiome linked to rheumatoid arthritis prognosis
New genomic study reveals that the microbiome could predict rheumatoid arthritis prognosis, potentially advancing treatments.
List view / Grid view
New genomic study reveals that the microbiome could predict rheumatoid arthritis prognosis, potentially advancing treatments.
In pre-clinical studies, senolytic drugs were found to reduce inflammation and death from COVID-19 in older mice.
Researchers have found that ischemic wounds in pre-clinical models which were treated with a purified exosomal product were healed.
A proton therapy that targets cancer cells which are resistant to treatment has shown success, sparing surrounding healthy cells.
After viral pneumonia in elderly mice, there is an accumulation of dysfunctional tissue-resident memory T cells in the lungs which scientists suggest may drive chronic inflammation and fibrosis.
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Researchers have shown that blocking a particular enzyme causes chemotherapy to become more effective against pancreatic cancers in pre-clinical studies.
A study has shown that a mutated form of the Ebola virus protects macaque models against the disease, demonstrating an opportunity for a drug target.
A method has been developed to reprogram stem cells using the measles virus vector, cutting a four-step process to only one stage...
Researchers have identified the drug estradiol as a potential new treatment for a subset of women with triple-negative breast cancer...
Germ line genetic testing analyses blood samples and evaluates inherited genetic changes that increase the risk of certain cancers in an individual...
A new system, pGENMi, could predict genomic features associated with drug responses, by identifying differences in gene expression...
Researchers have demonstrated how a pixelated gene expression tool can accurately measure RNA levels more quickly than existing methods allow.
New diagnoses for two types of skin cancer increased in recent years, according to a Mayo Clinic-led team of researchers.